Dublin, Ohio-based Cardinal Health plans to acquire Conshohocken, Pa.-based Viasys for approximately $1.5 billion, including the assumption of outstanding debt. Viasys Healthcare Inc. is a global, research-based medical technology company focused on respiratory, neurology and orthopedic products.
According to Cardinal, the acquisition will enable the company to:
Â· Deliver comprehensive bedside, patient safety offerings to acute-care customers.
Â· Better serve customers globally.
Â· Enhance its product and intellectual property portfolio.
Â· Realize synergies through existing capabilities and platforms.
Under the agreement, Cardinal Health will acquire Viasys in a two-step transaction. In the first step, Cardinal will make a cash tender offer to acquire all outstanding shares of Viasys common stock at $42.75 per share. The second step will consist of a merger in which the holders of the outstanding shares of Viasys common stock that were not purchased in the tender offer will receive the same per share price paid in the tender offer, in cash, without interest.
Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.